BIOT
•
Equity
L&G PHARMA BREAKTHROUGH UCITS ETF
TER (bps):
49
AUM (USD m):
65
ISIN:
IE00BF0H7608
Domicile:
Ireland
Share Class Currency:
USD
ESG:
No
Geographical Focus:
Global
As of:
19 May 2023
Climate Fund:
No
Benchmark
The Solactive Pharma Breakthrough Value Index aims to track the performance of a basket of stocks of companies that are actively engaged in the research, development and/or manufacturing of orphan drugs. it uses a two-fold approach that is primarily based on the trend in the valuation of a company’s orphan drug portfolio and its overall revenue forecasts. The Index selects stocks that meet certain size and liquidity requirements.
RELATED ARTICLES
MOST READ
1
Analysis
How BlackRock came to dominate ETFs in Europe
2
Industry Updates
BlackRock to launch risk-based ETF savings plans with Bux
3
Industry Updates
One ETF has returned over 100% this year
4
Analysis
US debt ceiling ‘crisis’: A buying opportunity in ultrashort Treasury ETFs
5
Industry Updates